These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11440218)

  • 21. Antimicrobial-induced endotoxaemia in patients with sepsis in the field of acute pyelonephritis.
    Giamarellos-Bourboulis EJ; Perdios J; Gargalianos P; Kosmidis J; Giamarellou H
    J Postgrad Med; 2003; 49(2):118-22. PubMed ID: 12867685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ampicillin plus mecillinam vs. cefotaxime/cefadroxil treatment of patients with severe pneumonia or pyelonephritis: a double-blind multicentre study evaluated by intention-to-treat analysis.
    Cronberg S; Banke S; Bruno AM; Carlsson M; Elmrud H; Elowsson S; Josefsson K; Lindholm AC; Montelius H; Neringer R
    Scand J Infect Dis; 1995; 27(5):463-8. PubMed ID: 8588136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of ceftibuten versus amoxicillin/clavulanate in the treatment of acute sinusitis.
    Sterkers O
    Chemotherapy; 1997; 43(5):352-7. PubMed ID: 9309369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
    Higuera F; Hidalgo H; Feris J; Giguere G; Collins JJ
    J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].
    Aparicio JR; Such J; Gutiérrez A; Pérez-Mateo M; Plaza J; Arroyo A
    Med Clin (Barc); 1999 Sep; 113(7):241-5. PubMed ID: 10544377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Program of empirical antibacterial therapy of community-acquired pneumonia].
    Suvorova MP; Iakovlev SV; Shakhova TV; Dvoretskiĭ LI
    Antibiot Khimioter; 1998; 43(7):31-5. PubMed ID: 9727165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cost-effectiveness analysis of treatment strategies for acute uncomplicated pyelonephritis in women.
    Yen ZS; Davis MA; Chen SC; Chen WJ
    Acad Emerg Med; 2003 Apr; 10(4):309-14. PubMed ID: 12670842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of cefuroxime administration on endotoxin (LPS) and tumour necrosis factor-alpha (TNFalpha) blood levels in patients suffering from acute pyelonephritis: a preliminary report.
    Giamarellou-Bourboulis EJ; Perdios J; Lelekis M; Eoconomou E; Tsouroulas P; Giamarellou H
    Int J Antimicrob Agents; 1999 Feb; 11(2):115-9. PubMed ID: 10221414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis.
    Chang UI; Kim HW; Wie SH
    Yonsei Med J; 2015 Sep; 56(5):1266-73. PubMed ID: 26256969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of the efficacy of oral norfloxacin in pyelonephritis and nosocomial urinary tract infection.
    Corrado ML; Roylance PJ; Struble WE; Lancaster MS
    Eur Urol; 1990; 17 Suppl 1():24-9. PubMed ID: 2191866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
    Klein GL; Whalen E; Echols RM; Heyd A
    J Otolaryngol; 1998 Feb; 27(1):10-6. PubMed ID: 9511113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis.
    Mouton Y; Ajana F; Chidiac C; Capron MH; Home P; Masquelier AM
    Am J Med; 1992 Apr; 92(4A):87S-90S. PubMed ID: 1316078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative clinical efficacy and tolerance of cefuroxime axetil (zinnat) and ceftibuten (cedex) in patients with acute sinusitis].
    Otvagin IV; Kamanin EI; Strachunskiĭ LS; Kozlov SN
    Vestn Otorinolaringol; 2001; (5):29-32. PubMed ID: 11699089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are first-generation cephalosporins obsolete? A retrospective, non-inferiority, cohort study comparing empirical therapy with cefazolin versus ceftriaxone for acute pyelonephritis in hospitalized patients.
    Hobbs AL; Shea KM; Daley MJ; Huth RG; Jaso TC; Bissett J; Hemmige V
    J Antimicrob Chemother; 2016 Jun; 71(6):1665-71. PubMed ID: 26983859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the efficacy and tolerability of once-daily ceftibuten and twice-daily cefprozil in the treatment of children with acute otitis media.
    Blumer JL; Forti WP; Summerhouse TL
    Clin Ther; 1996; 18(5):811-20. PubMed ID: 8930425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
    Bach D; van den Berg-Segers A; Hübner A; van Breukelen G; Cesana M; Plétan Y
    J Urol; 1995 Jul; 154(1):19-24. PubMed ID: 7776420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial.
    Pimentel FL; Dolgner A; Guimarães J; Quintas M; Mário-Reis J
    J Chemother; 1998 Apr; 10(2):122-7. PubMed ID: 9603637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefepine vs. ceftazidime treatment of pyelonephritis: a European, randomized, controlled study of 300 pediatric cases. European Society for Paediatric Infectious Diseases (ESPID) Pyelonephritis Study Group.
    Schaad UB; Eskola J; Kafetzis D; Fishbach M; Ashkenazi S; Syriopoulou V; Boulesteix J; De Pril V; Grès JJ; Rollin C
    Pediatr Infect Dis J; 1998 Jul; 17(7):639-44. PubMed ID: 9686732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli.
    Suh JW; Yang KS; Kim SB; Kim JH; Sohn JW; Kim MJ; Yoon YK
    Infect Dis (Lond); 2018 Mar; 50(3):241-244. PubMed ID: 29086602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.